What medications Syra Rx offers
GLP-1 medications for weight care, and peptides marketed for energy and wellbeing. What each one is, how it works, and what the evidence supports.
Syra Rx splits its offering into two categories. Both are prescription-only and both run through the same clinician-review process — there is no “Syra Rx supplement” in either category that you can simply buy. This page explains what each medication is in plain language, without overstating what it does.
Read this first. Syra Rx’s primary programme provides compounded medications. Compounded drugs are not FDA-approved, which means the FDA has not reviewed them for safety, effectiveness or quality. Where a medication below is FDA-approved as a brand-name product, that approval does not transfer to a compounded version containing the same active ingredient. The FDA has been explicit on this point.
Weight care: GLP-1 medications
Semaglutide
Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after eating; it signals the pancreas to release insulin, slows how quickly the stomach empties, and acts on appetite centres in the brain. A GLP-1 agonist mimics that hormone, which is why people taking it commonly report feeling full sooner and thinking about food less.
Semaglutide is the active ingredient in several FDA-approved brand-name products, approved as an injectable, with an oral tablet version also approved. Those approvals belong to the branded products. A compounded semaglutide preparation is a different thing in regulatory terms, even though the active ingredient shares a name.
Common side effects are mostly gastrointestinal and tend to be worst when starting or increasing a dose: nausea, vomiting, diarrhoea, constipation, reflux. Most people find these ease over time. Serious effects are less common but real — pancreatitis, gallbladder problems, kidney issues from dehydration.
Tirzepatide
Tirzepatide works on two receptors rather than one: GLP-1 and GIP. Both are incretin hormones involved in blood sugar regulation and appetite. Syra Rx describes it as a dual-pathway option for patients who need more.
The side-effect profile is broadly similar to semaglutide and similarly dominated by gastrointestinal effects. Our comparison guide goes into the differences between the two in more detail.
Important safety information for GLP-1 medications. These medications are used as part of medical weight-management programmes for adults who meet specific clinical criteria. They may cause side effects, some of which can be serious, including the potential risk of thyroid C-cell tumours. Do not use GLP-1 medications if you or a family member have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always consult a healthcare professional before starting or changing any medication.
Peptide therapy
Syra Rx groups NAD+, sermorelin and tesamorelin under anti-aging, marketed around energy, focus and how you feel day to day. These deserve a more cautious framing than the GLP-1 medications, because the evidence base is thinner and the regulatory position has been moving.
NAD+
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, central to how cells convert nutrients into usable energy and to several DNA repair processes. NAD+ levels decline with age, which is the basis for the interest in supplementing it.
That underlying biology is well established. What is much less established is whether administering NAD+ or its precursors produces the energy, focus and recovery benefits commonly claimed. Research is ongoing and genuinely interesting, but it is early. Treat confident claims about NAD+ outcomes with scepticism, wherever you see them.
Sermorelin
Sermorelin is a growth hormone–releasing hormone analogue. Rather than supplying growth hormone directly, it signals the pituitary gland to produce more of its own. It has an established clinical history in diagnostic use and in paediatric growth hormone deficiency.
Its use in adults for anti-aging and wellbeing purposes is off-label and considerably less well-supported.
Tesamorelin
Tesamorelin is another growth hormone–releasing factor analogue. It has an FDA-approved indication, in a specific branded form, for reducing excess abdominal fat in people with HIV-associated lipodystrophy. Use outside that indication is off-label.
Compounded peptides are a shifting area. Regulatory treatment of compounded peptide products has changed repeatedly through 2025 and 2026, including review of which peptides may be compounded at all. Ask specifically what you are being prescribed, in what form, and by which pharmacy, and confirm the current position rather than relying on any webpage.
How these medications are typically used
Two practical points apply across the GLP-1 options and are worth knowing before you start.
Dosing is titrated. You do not begin at a maintenance dose. Prescribers typically start low and increase in steps over weeks, because gastrointestinal side effects track closely with how fast the dose rises. Rushing the schedule is the most common way people make themselves miserable on these medications. Follow the plan you are given rather than the plan you find in a forum.
Medication is one part of it. GLP-1 medications reduce appetite; they do not supply protein, build muscle or create an eating pattern you can sustain afterwards. Clinical programmes pair them with nutrition and activity guidance for that reason. Syra Rx describes practical guidance alongside the prescription. Treat that as part of the treatment rather than an optional extra.
Storage and handling
Injectable GLP-1 medications generally require refrigeration, and compounded preparations may have specific storage windows and in-use expiry periods that differ from brand-name products. Read the label and instructions that arrive with your shipment rather than assuming the rules match something you have used before. If a shipment arrives warm or appears to have had its cold chain broken, contact the pharmacy before using it.
What you will actually receive
Syra Rx discloses that it does not produce, manufacture or prescribe any medications, that product appearance may differ from website images, and that products will not bear the Syra Rx name or logo. Anything shipped to you is prepared and labelled by the dispensing pharmacy. Read that label, and keep it.
The honest summary
GLP-1 medications have a substantial evidence base behind them for weight management in appropriate patients, and a well-characterised side-effect profile. The peptides sit in a different category: plausible mechanisms, much thinner outcome evidence, and a regulatory picture that is actively unsettled. A clinician who knows your history is better placed than any website to tell you whether either is sensible for you.
Discuss options with a licensed clinician
The assessment routes your history to a U.S.-licensed provider who decides what, if anything, is appropriate.
See If You QualifyIndependent site. We may earn a commission if you start an assessment through this link. Eligibility is decided by a licensed clinician, not by us.